A shocking new study shows 1.3 billion people worldwide had fatty liver disease in 2023. The analysis, based on data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2023, found that 1·8 billion (95% UI 1·6 to 2·0) individuals are likely to have MASLD or metabolically associated steatotic liver disease by 2050, representing a 42% increase from 2023.
The numbers, published inThe Lancet Gastroenterology and Hepatology journaland based on data from the Global Burden of Diseases study, paint a picture of slow-motion catastrophe. Since 1990, cases of MASLD have surged by 143 percent. Not doubled. Tripled. We’re talking a spike so aggressive it’s almost hard to grasp without context. And it’s not slowing down. By 2050, researchers project nearly 1.8 billion people will have the disease. That’s a 38 percent jump from today.
The silent killer that doesn’t feel like much
MASLD used to have a different name. For decades, doctors called it nonalcoholic fatty liver disease, or NAFLD. The rebrand happened because the old name missed the point. It’s metabolic. It’s tied to how your body actually functions, how it processes sugar, manages insulin, and stores fat. Most people with MASLD feel nothing. The liver doesn’t have nerve endings. You can damage it pretty badly and never know. This is why the disease spreads so quietly.
Someone might have been accumulating fat in their liver for a decade, slowly progressing, while checking the calendar and feeling fine. Then one day they get an ultrasound for an unrelated reason and suddenly there’s fat where there shouldn’t be. Or worse, they don’t find out until their liver is already starting to fail.That’s the real crisis. Researchers forming the GBD 2023 MASLD Collaborators also found that regions such as North Africa and the Middle East had disproportionately higher rates of MASLD than other regions.
The risk factors you actually need to know
High blood sugar tops the list. If your fasting glucose is creeping up or your A1C levels are beginning to climb, your liver is probably already beginning to accumulate fat. Type 2 diabetes is almost always paired with fatty liver disease, the two go together.Obesity matters too, though it’s not the only problem. If your BMI is north of 30, your risk goes up substantially. But again, skinny people get this disease too, which is why the focus on weight alone can miss the actual threat.Metabolic syndrome is like the red flag waving directly in your face. When you combine high blood sugar, high blood pressure, excess abdominal fat, and abnormal cholesterol, you’ve created the perfect storm for MASLD.And age matters. People in their 80s have the highest rates, which makes sense, they’ve had decades to accumulate liver fat. But the disease is showing up younger every year, which is genuinely alarming.The research team also found that although more people are developing the disease, the overall impact on health — measured in years lost due to illness or death — has remained stable.The result suggested that advances in treatment and care are helping people live longer and healthier, and that the increase in the number of cases is mostly happening in the early stages of the disease, the researchers said.
